ROBERTO ALVAREZ GARCIA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MIAMI, FL NPI 1942748652

General Payments — all program years on this page

$540.10

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 29
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $397.26 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $397.2620

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $142.849
2024 $397.2620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086742527 Novartis Pharmaceuticals Corporation $15.86 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100242342 Novo Nordisk Inc $15.76 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100262209 Novo Nordisk Inc $15.24 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100627992 Novo Nordisk Inc $19.91 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105586144 AstraZeneca Pharmaceuticals LP $13.54 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105595221 AstraZeneca Pharmaceuticals LP $23.37 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106433700 ABBVIE INC. $20.94 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115833781 GlaxoSmithKline, LLC. $18.62 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116364979 GlaxoSmithKline, LLC. $14.08 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116481841 GlaxoSmithKline, LLC. $15.00 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117493716 Amgen Inc. $17.88 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118245949 Boehringer Ingelheim Pharmaceuticals, Inc. $20.79 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118245951 Boehringer Ingelheim Pharmaceuticals, Inc. $26.85 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124756110 Grifols USA, LLC $24.64 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124756112 Grifols USA, LLC $22.79 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124756114 Grifols USA, LLC $24.64 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131099332 PFIZER INC. $24.79 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132857498 ATRICURE, INC. $29.95 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147369858 Mylan Specialty L.P. $13.32 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153383946 Dexcom, Inc. $19.29 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.